Medicines and Healthcare Products Regulatory Agency
Generated by Meeveem AI
"Medicines and Healthcare products Regulatory Agency regulates UK medicines and medical devices."
About Medicines and Healthcare Products Regulatory Agency
The Medicines and Healthcare products Regulatory Agency (MHRA) regulates medicines, medical devices and blood components for transfusion in the UK. Based in London, this executive agency uses science and data to assess safety, quality and effectiveness, oversee supply chains and support medical innovation. Its Yellow Card scheme collects reports of suspected side effects and device incidents.
Established in 2003, the agency combines regulatory work with scientific research, biological standards and advice for product developers. Its teams work with UK and international partners across the lifecycle of healthcare products. The MHRA also provides scientific advice during medicines development and regulatory review, helping developers address evidence requirements.
Learning and development
Staff have access to in-house courses and Civil Service Learning, with external degrees, diplomas and MSc courses available subject to manager approval. A three-stage induction introduces teams and departments, while monthly continuing professional development programmes support skills and knowledge across the agency.
Scientific and regulatory settings
The agency combines its Canary Wharf offices with laboratories at South Mimms and a digital hub in Leeds. This brings regulatory assessment, laboratory science and digital work into one organisation, alongside the operational and corporate functions supporting its public health responsibilities.
1738
Team Members
2003
Founded
NHS
Sector
Hybrid
Work Environment